{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T15:14:53Z","timestamp":1792163693310,"version":"4.4.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2004,5,1]],"date-time":"2004-05-01T00:00:00Z","timestamp":1083369600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["General Hospital Psychiatry"],"published-print":{"date-parts":[[2004,5]]},"DOI":"10.1016\/j.genhosppsych.2004.02.002","type":"journal-article","created":{"date-parts":[[2004,5,4]],"date-time":"2004-05-04T11:29:28Z","timestamp":1083670168000},"page":"233-236","source":"Crossref","is-referenced-by-count":5,"title":["Mood-stabilizer-maintained, remitted bipolar patients: taper and discontinuation of adjunctive antipsychotic medication"],"prefix":"10.1016","volume":"26","author":[{"given":"John R.","family":"Saksa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.Bruce","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott W.","family":"Woods","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.genhosppsych.2004.02.002_BIB1","first-page":"375","article-title":"Chronic neuroleptic use in manic-depressive illness","volume":"29","author":"Sernyak","year":"1993","journal-title":"Psychopharmacol Bull"},{"key":"10.1016\/j.genhosppsych.2004.02.002_BIB2","series-title":"Manic-depressive illness","author":"Goodwin","year":"1990"},{"key":"10.1016\/j.genhosppsych.2004.02.002_BIB3","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1176\/ajp.151.1.133","article-title":"Neuroleptic exposure following inpatient treatment of acute mania with lithium and neuroleptic","volume":"151","author":"Sernyak","year":"1994","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.genhosppsych.2004.02.002_BIB4","first-page":"147","article-title":"Factors associated with maintenance antipsychotic treatment of patients with bipolar disorder","volume":"57","author":"Keck","year":"1996","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.genhosppsych.2004.02.002_BIB5","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/0010-440X(88)90032-6","article-title":"Relapse in delusional depression","volume":"29","author":"Aronson","year":"1988","journal-title":"Compr Psychiatry"},{"key":"10.1016\/j.genhosppsych.2004.02.002_BIB6","first-page":"533","article-title":"Is there a role for neuroleptics in bipolar depression?","volume":"55","author":"Hendrick","year":"1994","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.genhosppsych.2004.02.002_BIB7","doi-asserted-by":"crossref","first-page":"537","DOI":"10.2165\/00023210-200115070-00004","article-title":"Bodyweight gain associated with atypical antipsychotics","volume":"15","author":"Russell","year":"2001","journal-title":"CNS Drugs"},{"key":"10.1016\/j.genhosppsych.2004.02.002_BIB8","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/00004714-200108000-00003","article-title":"Novel antipsychotics and severe hyperlipidemia","volume":"21","author":"Meyer","year":"2001","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.genhosppsych.2004.02.002_BIB9","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1177\/070674370104600308","article-title":"Antipsychotic metabolic effects","volume":"46","author":"McIntyre","year":"2001","journal-title":"Can J Psychiatry"},{"key":"10.1016\/j.genhosppsych.2004.02.002_BIB10","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1192\/bjp.175.4.391b","article-title":"Olanzapine and tardive dyskinesia","volume":"175","author":"Woods","year":"1999","journal-title":"Br J Psychiatry"},{"issue":"4 Suppl","key":"10.1016\/j.genhosppsych.2004.02.002_BIB11","first-page":"1","article-title":"Practice guideline for the treatment of patients with bipolar disorder","volume":"159","year":"2002","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.genhosppsych.2004.02.002_BIB12","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1176\/ajp.156.8.1164","article-title":"Clinical outcome in a randomized 1-year trial of clozapine versus treatment as usual for patients with treatment-resistant illness and a history of mania","volume":"156","author":"Suppes","year":"1999","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.genhosppsych.2004.02.002_BIB13","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S0006-3223(00)00961-6","article-title":"Pharmacologic agents for the treatment of acute bipolar mania","volume":"48","author":"McElroy","year":"2000","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.genhosppsych.2004.02.002_BIB14","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1176\/appi.ajp.159.6.1011","article-title":"Olanzapine versus divalproex in the treatment of acute mania","volume":"159","author":"Tohen","year":"2002","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.genhosppsych.2004.02.002_BIB15","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1034\/j.1399-5618.2002.40103.x","article-title":"The impact of response to previous mood stabilizer therapy on response to olanzapine versus placebo for acute mania","volume":"4","author":"Baker","year":"2002","journal-title":"Bipolar Disord"},{"key":"10.1016\/j.genhosppsych.2004.02.002_BIB16","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1001\/archpsyc.59.1.62","article-title":"Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy","volume":"59","author":"Tohen","year":"2002","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.genhosppsych.2004.02.002_BIB17","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1097\/00004714-200110000-00002","article-title":"Olanzapine as long-term adjunctive therapy in treatment-resistant bipolar disorder","volume":"21","author":"Vieta","year":"2001","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.genhosppsych.2004.02.002_BIB18","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0165-0327(01)00435-9","article-title":"Role of risperidone in bipolar II","volume":"67","author":"Vieta","year":"2001","journal-title":"J Affect Disord"},{"key":"10.1016\/j.genhosppsych.2004.02.002_BIB19","doi-asserted-by":"crossref","first-page":"273","DOI":"10.4088\/JCP.v62n0410","article-title":"Long-term olanzapine therapy in the treatment of bipolar I disorder","volume":"62","author":"Sanger","year":"2001","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.genhosppsych.2004.02.002_BIB20","first-page":"64","article-title":"Psychopharmacology for the clinician","volume":"25","author":"Woods","year":"2000","journal-title":"J Psychiatry Neurosci"}],"container-title":["General Hospital Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163834304000246?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163834304000246?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T15:22:38Z","timestamp":1682695358000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163834304000246"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,5]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2004,5]]}},"alternative-id":["S0163834304000246"],"URL":"https:\/\/doi.org\/10.1016\/j.genhosppsych.2004.02.002","relation":{},"ISSN":["0163-8343"],"issn-type":[{"value":"0163-8343","type":"print"}],"subject":[],"published":{"date-parts":[[2004,5]]}}}